Bengaluru: Biosense Technologies, which claims to provide quality, affordable and connected point-of-care diagnostics solutions for chronic diseases in India, has raised more than $1 million of direct equity funding from Menterra Venture Advisors and Artha Venture Challenge and more than $2 million of unlocked soft debt funding from their partner network. more

Mumbai: In an interview with DNA, Dr G N Mahapatra, head of department of non-invasive cardiology at Seven Hills Hospital, Mumbai explains how nuclear medicine can help avoid unnecessary angioplasty and why many cardiologists don’t prescribe it. more

New Delhi: A genetic mutation has been identified as the cause of obesity in 36-year-old Egyptian woman Eman Ahmed, who is believed to be the world’s heaviest woman, and is undergoing treatment in India to cure her morbid obesity. more

Mumbai: Dr Lal PathLabs, the oldest pathology lab chain in the country, plans to open a central lab in Kolkata in September, and another one in Lucknow by the end of 2018. Currently, it has one central lab in Delhi, besides 179 laboratories, most of them in north and east India. more

Washington: CellMax Life, a precision cancer blood-testing company, on Wednesday announced the availability of CellMax-LBx Liquid Biopsy in India. more

New Delhi: BD (Becton, Dickinson and Company), a global medical technology company, on Wednesday announced the launch of its next generation diagnostic instrument for the rapid identification of bacteria and detection of antimicrobial resistance (AMR). more

Pune: The global respiratory diagnostics market is projected to grow at a compound annual growth rate (CAGR) of 7.3 percent and reach $7.45 billion by 2021 from $5.24 billion in 2016, according to a new market research report by MarketsandMarkets. more

Pune: The global immunoassay market is expected to grow at a CAGR of 8.2 per cent from $17.16 billion in 2016 to $25.45 billion by 2021, according to a new market research report by MarketsandMarkets. more

Pune: Global Point of Care Diagnostics Market is expected to grow at a CAGR (compound annual growth rate) of 9.7 percent to reach $32.7 billion by 2022, according to Wise Guy Reports. more

Washington: The US Food and Drug Administration on Wednesday cleared for marketing the Xpert Carba-R Assay, an infection control aid that tests patient specimens to detect specific genetic markers associated with bacteria that are resistant to Carbapenem antibiotics. more